Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...

South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...

South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...

Lenacapavir, a groundbreaking HIV treatment, is set to transform South Africa’s approach to HIV prevention amidst funding ...

In response, the South African National Treasury allocated R750 million in emergency funding to prevent service interruptions ...

South Africa’s fight against HIV/Aids has received a boost with the USA government’s approval of the US President’s Emergency ...

23-year-old Othandiweyo Mkula from Tsolo in the Eastern Cape is on a mission to help prevent more young people in his community from acquiring HIV. Mkula tells Health-e News that when he tested ...

In the Durban township of Umlazi, the fight against HIV includes a battle against crime. People receiving antiretroviral (ARVs) treatment are being robbed of their medication. This happened to 24-year ...

Two Indian generic drugmakers — Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 ...

“PrEP, or pre-exposure prophylaxis, is medication for HIV-negative folks to take daily that really helps reduce their chances of getting HIV by over 99% when used correctly. It’s super effective after ...

India stands at the threshold of a historic opportunity – to support global efforts to end AIDS as a public health threat by 2032. Last year, two pivotal phase-3 clinical trials revealed remarkable ...